Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia induced cancer stem cell enrichment promotes resistance to androgen deprivation therapy in prostate cancer
Debbie O’Reilly, Patricia Johnson, Paul Buchanan
Steroids (2019) Vol. 152, pp. 108497-108497
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 326
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou, Libin Zou, Hangyu Liao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 692-707
Open Access | Times Cited: 72
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
Poornima Verma, Neha Shukla, Shivani Kumari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188887-188887
Closed Access | Times Cited: 36
The role of transcription factors in prostate cancer progression
Jongeun Lee, Yoontae Lee
Molecules and Cells (2025), pp. 100193-100193
Open Access | Times Cited: 1
Hypoxia-mediated cancer stem cell resistance and targeted therapy
Xiaoyu Sun, Xuemei Lv, Yuanyuan Yan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110623-110623
Open Access | Times Cited: 68
Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression
Haoran Chen, Su-Ping Fang, Xudong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Astha Lamichhane, Hossein Tavana
Cellular and Molecular Bioengineering (2024) Vol. 17, Iss. 2, pp. 107-119
Open Access | Times Cited: 5
The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.
Michelle Shen, Shiqin Liu, Tanya Stoyanova
American journal of clinical and experimental urology (2021) Vol. 9, Iss. 1, pp. 73-87
Closed Access | Times Cited: 28
Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance
Sireesha V. Garimella, Siri Chandana Gampa, Pankaj Chaturvedi
Stem Cells and Cloning Advances and Applications (2023) Vol. Volume 16, pp. 19-41
Open Access | Times Cited: 11
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
Hisham F. Bahmad, Timothy Demus, Maya M. Moubarak, et al.
Medical Sciences (2022) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 18
β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase
Yifan Zhang, Yunlong Li
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Carnitine Palmitoyltransferase 1 Regulates Prostate Cancer Growth under Hypoxia
Leslimar Ríos-Colón, Pawan Kumar, Susy Kim, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6302-6302
Open Access | Times Cited: 20
Hypoxia promotes conversion to a stem cell phenotype in prostate cancer cells by activating HIF-1α/Notch1 signaling pathway
Kun Wu, Minghui Wu, Huan Yang, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 7, pp. 2138-2152
Closed Access | Times Cited: 7
Vaccinium myrtillus L. extract and its native polyphenol‐recombined mixture have anti‐proliferative and pro‐apoptotic effects on human prostate cancer cell lines
Massimo Del Bubba, Claudia Di Serio, Lapo Renai, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 2, pp. 1089-1098
Closed Access | Times Cited: 20
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Zhong Chen, Guojuan Wang, Min Guo, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
Elisa Grassi, Viola Ghiandai, Luca Persani
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 15
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer
Sujin Choi, Soonchul Lee, Hyun−Ju An, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer
Soo-Hyeon Moon, Ye-Jin Ok, Seon Yeong Hwang, et al.
Marine Drugs (2020) Vol. 18, Iss. 10, pp. 498-498
Open Access | Times Cited: 15
Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses
Xue Shui, Rong Xu, Caiqin Zhang, et al.
Laboratory Investigation (2021) Vol. 102, Iss. 4, pp. 332-340
Open Access | Times Cited: 13
Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs.
E. Jouberton, Aurélien Voissière, Frédérique Penault‐Llorca, et al.
HAL (Le Centre pour la Communication Scientifique Directe) (2022) Vol. 12, Iss. 3, pp. 1116-1128
Closed Access | Times Cited: 9
HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions
Shuanglong Xiong, Donglin Wang, Yin Tang, et al.
Gene (2023) Vol. 863, pp. 147288-147288
Closed Access | Times Cited: 5
NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
Taiga Seki, Yui Shimizu, Kyota Ishii, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1702-1702
Open Access | Times Cited: 12
Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense
Seema Bhuyan, Bidisha Pal, Lekhika Pathak, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Prostate cancer stem cells and their targeted therapies
Huilan Su, Liqun Huang, Jianjun Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top